Bispecific Antibodies in the Treatment of Hematologic Malignancies

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1396
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

PET in the Management of Hematologic Malignancies

PET Clinics
MedicineNuclear MedicineRadiologyRadiationImaging
2019English

Venous Thromboembolism in the Hematologic Malignancies

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Vaccine Therapy in Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Current Role of Genetics in Hematologic Malignancies

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Chemically Modified Bispecific Antibodies

Science-Business eXchange
2012English

Pharmacotherapy of Hematologic Malignancies With Tipifarnib

Clinical Medicine. Therapeutics
2009English

Leveraging Cancer Genome Information in Hematologic Malignancies

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy